KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Cash & Current Investments (2017 - 2025)

Historic Cash & Current Investments for Elanco Animal Health (ELAN) over the last 9 years, with Q3 2025 value amounting to $505.0 million.

  • Elanco Animal Health's Cash & Current Investments rose 306.12% to $505.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $505.0 million, marking a year-over-year increase of 306.12%. This contributed to the annual value of $468.0 million for FY2024, which is 3295.45% up from last year.
  • Latest data reveals that Elanco Animal Health reported Cash & Current Investments of $505.0 million as of Q3 2025, which was up 306.12% from $539.0 million recorded in Q2 2025.
  • Elanco Animal Health's Cash & Current Investments' 5-year high stood at $638.0 million during Q4 2021, with a 5-year trough of $318.0 million in Q1 2023.
  • Over the past 5 years, Elanco Animal Health's median Cash & Current Investments value was $460.0 million (recorded in 2022), while the average stood at $447.2 million.
  • In the last 5 years, Elanco Animal Health's Cash & Current Investments crashed by 5863.05% in 2021 and then surged by 4115.94% in 2025.
  • Elanco Animal Health's Cash & Current Investments (Quarter) stood at $638.0 million in 2021, then tumbled by 45.92% to $345.0 million in 2022, then rose by 2.03% to $352.0 million in 2023, then surged by 32.95% to $468.0 million in 2024, then increased by 7.91% to $505.0 million in 2025.
  • Its Cash & Current Investments stands at $505.0 million for Q3 2025, versus $539.0 million for Q2 2025 and $487.0 million for Q1 2025.